AOAAM Education
Saturday, October 3, 2020
Introduction and Welcome
A Genetic and Neurobiologic Understanding of Addiction 7:30am - 8:00am EST
8:00am - 8:50am EST
View Session
Welcome to the AOAAM Addiction Medicine Board Certification Review Course! This session is a review of the genetic underpinnings of the individual susceptibility and development of addiction. This will be tied into the potential environmental and epigenetic influences on genetics. Flowing from there will be a review of the current understanding of the neurobiology of addiction, from first reward to the development of the disease.
If you have CME questions, please reach out to Review@aoaam.org
Overview
Welcome to the AOAAM Addiction Medicine Board Certification Review Course! This session is a review of the genetic underpinnings of the individual susceptibility and development of addiction. This will be tied into the potential environmental and epigenetic influences on genetics. Flowing from there will be a review of the current understanding of the neurobiology of addiction, from first reward to the development of the disease.
If you have CME questions, please reach out to Review@aoaam.org
Agenda and Speakers
Introduction and Welcome
7:30am - 8:00am
Julie Kmiec, DO, FAOAAM
A Genetic and Neurobiologic Understanding of Addiction
8:00am - 8:50am
Stephen Wyatt, DO, FAOAAM
A Comprehensive Review of Opioid Use Disorder 9:00am - 10:50 am EST
View Session
This session reviews the epidemiology of opioid use disorder and opioid overdose deaths, diagnosis of opioid use disorder, opioid intoxication, and opioid withdrawal, in addition to treatments for opioid withdrawal, and medications for opioid use disorder.
If you have CME questions, please reach out to Review@aoaam.org
Overview
This session reviews the epidemiology of opioid use disorder and opioid overdose deaths, diagnosis of opioid use disorder, opioid intoxication, and opioid withdrawal, in addition to treatments for opioid withdrawal, and medications for opioid use disorder.
If you have CME questions, please reach out to Review@aoaam.org
Agenda and Speakers
A Comprehensive Review of Opioid Use Disorder
9:00am - 10:50am
Julie Kmiec, DO, FAOAAM
Tobacco Use Disorders 11:00am - 11:50am EST
View Session
This presentation will review the diagnoses, epidemiology, and management of Tobacco Use Disorders to include smokeless tobacco, E-Cigarettes, co-occurring disorders, and medication assisted options.
If you have CME questions, please reach out to Review@aoaam.org
Overview
This presentation will review the diagnoses, epidemiology, and management of Tobacco Use Disorders to include smokeless tobacco, E-Cigarettes, co-occurring disorders, and medication assisted options.
If you have CME questions, please reach out to Review@aoaam.org
Agenda and Speakers
Tobacco Use Disorders
11:00am - 11:50am
R. Gregory Lande, DO, FAOAAM
Lunch time Q&A 12:00pm - 12:30pm EST
View Session
Question and Answer Session with today's speakers.
If you have CME questions, please reach out to Review@aoaam.org
Overview
Question and Answer Session with today's speakers.
If you have CME questions, please reach out to Review@aoaam.org
Agenda and Speakers
Lunch time Q&A
12:00pm - 12:30pm
Julie Kmeic, DO, FAOAAM / Stephen Wyatt, DO, FAOAAM / R. Gregory Lande, DO, FAOAAM
Cannabis / Medical Marijuana 12:30pm - 1:20pm EST
View Session
This session reviews the epidemiology of cannabis use disorder, diagnosis of cannabis use disorder, cannabis intoxication, and cannabis withdrawal. Medical marijuana policies and legalization of cannabis will be reviewed.
If you have CME questions, please reach out to Review@aoaam.org
Overview
This session reviews the epidemiology of cannabis use disorder, diagnosis of cannabis use disorder, cannabis intoxication, and cannabis withdrawal. Medical marijuana policies and legalization of cannabis will be reviewed.
If you have CME questions, please reach out to Review@aoaam.org
Agenda and Speakers
Cannabis / Medical Marijuana
12:30pm - 1:20pm
Marla Kushner, DO, FAOAAM
A Comprehensive Review of Alcohol Use Disorders 1:30pm - 3:20 pm EST
View Session
During this course there will be a review of the epidemiology of alcohol use disorders. There will information on the individual susceptibility to the disease and how understanding this can lead to individualize prevention. The screening for and brief intervention of alcohol use, will be reviewed along with the biologic markers of the disease. Treatment of alcohol use disorders will be reviewed from current withdrawal recommendations to post abstinent chronic care.
If you have CME questions, please reach out to Review@aoaam.org
Overview
During this course there will be a review of the epidemiology of alcohol use disorders. There will information on the individual susceptibility to the disease and how understanding this can lead to individualize prevention. The screening for and brief intervention of alcohol use, will be reviewed along with the biologic markers of the disease. Treatment of alcohol use disorders will be reviewed from current withdrawal recommendations to post abstinent chronic care.
If you have CME questions, please reach out to Review@aoaam.org
Agenda and Speakers
A Comprehensive Review of Alcohol Use Disorders
1:30pm - 3:20pm
Stephen Wyatt, DO, FAOAAM
Stimulant Use Disorder: Clinical & Practice Implications 3:30pm - 4:20pm EST
View Session
Stimulant use disorder includes amphetamines, methamphetamines, cocaine, and other stimulants. This presentation covers the neurobiology of stimulant use disorder, definition of stimulant use disorder and prevalence, its clinical manifestations including intoxication and withdrawal, misuse and diversion of prescription stimulants, and treatment approaches for individuals with stimulant use disorder.
If you have CME questions, please reach out to Review@aoaam.org
Overview
Stimulant use disorder includes amphetamines, methamphetamines, cocaine, and other stimulants. This presentation covers the neurobiology of stimulant use disorder, definition of stimulant use disorder and prevalence, its clinical manifestations including intoxication and withdrawal, misuse and diversion of prescription stimulants, and treatment approaches for individuals with stimulant use disorder.
If you have CME questions, please reach out to Review@aoaam.org
Agenda and Speakers
Stimulant Use Disorder: Clinical & Practice Implications
3:30pm - 4:20pm
Antoine Douaihy, MD
Q&A Session 4:30pm - 5:00 pm EST
View Session
Question and Answer Session with today's speakers
If you have CME questions, please reach out to Review@aoaam.org
Overview
Question and Answer Session with today's speakers
If you have CME questions, please reach out to Review@aoaam.org
Agenda and Speakers
Q&A Session
4:30pm - 5:00pm
Marla Kushner, DO, FAOAAM / Stephen Wyatt, DO, FAOAAM / Antoine Douaihy, MD